May 9th, 2007
Diabetes Drug Rosiglitazone Boosts Potency of Platinum-based Chemotherapy Agents
The widely used diabetes drug rosiglitazone has been found to dramatically boost the potency of platinum-based cancer drugs when administered together in a variety of cancer cell lines and mice with tumors.
Rosiglitazone, sold under the name Avandia®, enhances insulin receptors’ sensitivity in diabetics whose pancreas secretes too little insulin. It was approved in 1999 for […]
Recent Comments